For the quarter ending 2025-09-30, OGEN has $12,705,544 in assets. $2,874,108 in debts. $11,403,766 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 11,403,766 | 1,973,745 | ||
| Prepaid expenses and other current assets | 1,301,778 | 165,963 | ||
| Total current assets | 12,705,544 | 2,139,708 | ||
| Total assets | 12,705,544 | 2,139,708 | ||
| Accounts payable and accrued expenses | 2,479,272 | 1,267,423 | ||
| Short-term notes payable, net of debt issuance costs | 394,836 | 3,000,000 | ||
| Preferred stock, no par value 50,000,000 shares authorized 7,488,692 and 7,488,692 series f outstanding at june 30, 2025, and december 31, 2024, respectively | - | 0 | ||
| Total liabilities | 2,874,108 | 4,267,423 | ||
| Common stock, 0.001 par value 350,000,000 shares authorized 4,127,173 and 419,003 shares issued and outstanding at september 30, 2025, and december 31, 2024, respectively | 4,127 | 823 | ||
| Additional paid-in capital | 234,169,098 | 219,146,662 | ||
| Accumulated deficit | -224,341,789 | -221,275,200 | ||
| Total stockholders equity (deficit) | 9,831,436 | -2,127,715 | ||
| Total liabilities and stockholders equity (deficit) | 12,705,544 | 2,139,708 | ||
ORAGENICS INC (OGEN)
ORAGENICS INC (OGEN)